Clinical Trial Update: A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Aldoxorubicin in HIV-infected individuals with Kaposi's sarcoma has completed enrollment and posted results in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Aldoxorubicin (aldoxorubicin)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Kaposi's Sarcoma, HIV Positive | Phase 2 | Status: COMPLETED | Results posted: 2024-06-11